Literature DB >> 8968537

Discrimination between neuropeptide Y and peptide YY in the rat tail artery by the neuropeptide Y1-selective antagonist, BIBP 3226.

H Gicquiaux1, M Tschöpl, H N Doods, B Bucher.   

Abstract

1. The ability of the novel, nonpeptide, neuropeptide Y (NPY) Y1-selective antagonist, BIBP 3226 ¿(R)-N2-(diphenylacetyl)-N-[(4-hydroxyphenyl)methyl]-D-arginine amide¿, to antagonize the increase in perfusion pressure induced by NPY and peptide Y (PYY) was tested in the perfused rat tail artery, a postjunctional Y1-receptor bioassay, precontracted by 1 microM phenylephrine. 2. NPY and PYY produced a concentration-dependent enhancement of the vasoconstrictor response evoked by 1 microM phenylephrine. Although NPY and PYY are roughly equipotent, the maximal contractile response elicited by PYY was about twice that elicited by NPY. 3. Increasing concentrations of BIBP 3226 caused a parallel and rightward shift in the NPY concentration-response curve without depressing the maximal response. The contractile effect of NPY was potently inhibited in a competitive manner. The pA2 value for BIBP 3226 was 7.01 +/- 0.08, a value equivalent to that observed in the rabbit saphenous vein. Although increasing concentrations of BIBP 3226 shifted the concentration-response curve of PYY to the right without any significant decrease in the maximal vasoconstrictor response, the antagonism appeared non-competitive as the slope of the Schild plot was significantly different from unity (0.58 +/- 0.04). 4. In conclusion, these data confirm that BIBP 3226 is a potent and selective nonpeptide Y1 receptor antagonist. Moreover, they show that complex interactions occur between BIBP 3226 and postjunctional receptors activated by PYY. We postulate that BIBP 3226 might discriminate between the effects of NPY and PYY at the postjunctional level in the rat tail artery. It may be that distinct receptors for NPY and PYY exist; these may or may not allosterically interact with each other. Another working hypothesis would be that there is a single receptor complex with allosterically interacting binding sites for the two peptides.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8968537      PMCID: PMC1915806          DOI: 10.1111/j.1476-5381.1996.tb16040.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  36 in total

1.  Solubilization and hydrodynamic properties of active peptide YY receptor from rat jejunal crypts. Characterization as a Mr 44,000 glycoprotein.

Authors:  T Voisin; A Couvineau; C Rouyer-Fessard; M Laburthe
Journal:  J Biol Chem       Date:  1991-06-15       Impact factor: 5.157

2.  Some statistical methods useful in circulation research.

Authors:  S Wallenstein; C L Zucker; J L Fleiss
Journal:  Circ Res       Date:  1980-07       Impact factor: 17.367

3.  Interaction of peptide YY with rat intestinal epithelial plasma membranes: binding of the radioiodinated peptide.

Authors:  M Laburthe; B Chenut; C Rouyer-Fessard; K Tatemoto; A Couvineau; A Servin; B Amiranoff
Journal:  Endocrinology       Date:  1986-05       Impact factor: 4.736

4.  Evidence for different pre-and post-junctional receptors for neuropeptide Y and related peptides.

Authors:  C Wahlestedt; N Yanaihara; R Håkanson
Journal:  Regul Pept       Date:  1986-02

5.  Y1 and Y2 receptors for neuropeptide Y.

Authors:  S P Sheikh; R Håkanson; T W Schwartz
Journal:  FEBS Lett       Date:  1989-03-13       Impact factor: 4.124

6.  Centrally truncated and stabilized porcine neuropeptide Y analogs: design, synthesis, and mouse brain receptor binding.

Authors:  J L Krstenansky; T J Owen; S H Buck; K A Hagaman; L R McLean
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

7.  Neuropeptide Y co-exists and co-operates with noradrenaline in perivascular nerve fibers.

Authors:  E Ekblad; L Edvinsson; C Wahlestedt; R Uddman; R Håkanson; F Sundler
Journal:  Regul Pept       Date:  1984-04

8.  Morphine allosterically modulates the binding of [3H]leucine enkephalin to a particulate fraction of rat brain.

Authors:  R B Rothman; T C Westfall
Journal:  Mol Pharmacol       Date:  1982-05       Impact factor: 4.436

9.  Cloning and functional expression of a human neuropeptide Y/peptide YY receptor of the Y1 type.

Authors:  D Larhammar; A G Blomqvist; F Yee; E Jazin; H Yoo; C Wahlested
Journal:  J Biol Chem       Date:  1992-06-05       Impact factor: 5.157

10.  Characterization of vascular neuropeptide Y receptors.

Authors:  L Grundemar; S E Jonas; N Mörner; E D Högestätt; C Wahlestedt; R Håkanson
Journal:  Br J Pharmacol       Date:  1992-01       Impact factor: 8.739

View more
  1 in total

1.  Heterogeneity of the neuropeptide Y (NPY) contractile and relaxing receptors in horse penile small arteries.

Authors:  Dolores Prieto; Luis Rivera de Los Arcos; Pilar Martínez; Sara Benedito; Albino García-Sacristán; Medardo Hernández
Journal:  Br J Pharmacol       Date:  2004-11-22       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.